Markus Enzelberger
InvestorPartner at Versant Ventures
Munich, Germany
Writes $100K – $5M checks · typically $1.5M
About
Markus is a Versant partner in Basel who helps launch new companies from the firm's Ridgeline Discovery Engine. A drug discovery and protein engineering expert, he previously served as CSO and management board member of MorphoSys, which he joined in 2002, and holds a Ph.D. from the Technical University of Stuttgart.
Experience
- Versant VenturesPartnercurrent2020 — presentBasel, Basel, Switzerland
- Versant VenturesEntrepreneur in Residence2020Basel, Basel, Switzerland
- Granite BioBoard Membercurrent2021 — presentBasel, Switzerland
- Serac BiosciencesBoard Membercurrent2023 — present
- Red Ridge BioBoard Membercurrent2024 — presentBasel, Switzerland
- Abdera TherapeuticsBoard Observercurrent2021 — present
- Ridgeline DiscoveryBoard Membercurrent2020 — present
- Cimeio TherapeuticsBoard Membercurrent2020 — present
- SHS CapitalSenior Advisorcurrent2017 — present
- T-knifeBoard Observercurrent2020 — present
- SixPeaks BioBoard Member2023 — 2025Basel, Switzerland
- Matterhorn BiosciencesBoard Member2022 — 2025Basel, Switzerland
- Develco Pharma Schweiz AGAufsichtsratsmitglied2022 — 2024Basel, Switzerland
- Vertical BioscienceBoard Member2020 — 2023Basel
- Vector BioPharmaBoard Member2020 — 2023
- GNA Biosolutions GmbHAufsichtsratsmitglied2018 — 2021Martinsried
- MorphoSys AGCSO2017 — 2020Greater Munich Metropolitan Area
- MorphoSys AGinterim-CSO2017Greater Munich Metropolitan Area
- MorphoSys AGSenior Vice President2002 — 2017Greater Munich Metropolitan Area
- MorphoSys AGVice President2002 — 2012
Education
- CaltechPostdoc, Applied Physics1999 — 2002
- University of StuttgartPromotion, Chemie1990 — 1999
Skills & more
Pharmaforschung4Biowissenschaften10Biotechnologie13Pharmaindustrie14Molekularbiologie10Technologietransfer7Biochemie4Biopharmazeutika1Immunologie2Arzneimittelentwicklung7BiokatalyseAntikörper2
+8 more
ProteinchemieForschung und EntwicklungTechnology TransferClinical DevelopmentOnkologieBiopharmaceuticalsBiotechnologyTechnologyFrom Markus's professional profile.
Same school
Also attended Caltech84
Shaun MaguirePartner at Sequoia CapitalScott BillerInvestor at GV (Google Ventures)Seth LieblichInvestment Team at 8VCWen HsiehFounding Managing Partner at Matter Venture PartnersHaomiao HuangFounding Partner at Matter Venture PartnersJordan CroomInvestor at Side Door Ventures
+ 78 more
Also attended University of Stuttgart18
Samuel GilCEO & General Partner at JME VenturesNapat NantavechsantiPartner, Growth and Finance at Beacon VCMichael BauerOperating Partner - Energy at ClimacticGiulio BrugnaroVenture Designer at Founders FactoryPatrick HerlingerInvestment Manager at LBBW Venture Capital GmbHFrank MühlenbeckManaging Director at LBBW Venture Capital GmbH
+ 12 more
Shared employers
Also worked at Serac Biosciences1
Also worked at Red Ridge Bio4
Also worked at SHS Capital15
Hubertus LeonhardtSenior Partner at SHS CapitalCornelius MaasPartner at SHS CapitalSascha AlilovicManaging Partner at SHS CapitalDavid WehnerSenior Investment Manager at SHS CapitalLukas MaucherDeputy Managing Partner, CFO at SHS CapitalGuillaume BalzSenior Investment Manager at SHS Capital
+ 9 more
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures




























